Replies to post #331328 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Oh and can kicked down the road well into H2 2022.

[Steady_T]

These changes are consistent with Missling's statements in the Cantor interview. He said that biomarkers have become more important as a key factor of success along with efficacy. So it looks like they have added a number of measures that would corelate as biomarkers.